Medtech In 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models

Medtech manufacturers saw 2014 as the year of the medtech mega-merger and a rebound in IPOs. But the market is changing, and companies are increasingly cast as service providers who must deliver value.

The year 2014 was a heady one for medtech M&A, with bigger deals and more invested in them than ever before – $89.3 billion, according to Informa’s Strategic Transactions.

A lot of the 2014 M&A impetus was driven by pressures in the US to find a way around the...

More from Deal-Making

More from In Vivo